More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$12.59B
EPS
-2.09
P/E ratio
--
Price to sales
1.08
Dividend yield
0.164%
Beta
0.657378
Previous close
$23.90
Today's open
$23.93
Day's range
$23.84 - $24.47
52 week range
$15.73 - $30
show more
CEO
Andrew P. Hider
Employees
37500
Headquarters
Deerfield, IL
Exchange
New York Stock Exchange
Shares outstanding
516995999
Issue type
Common Stock
Healthcare
Medical Equipment & Supplies
Baxter to Host Third-Quarter 2026 Financial Results Conference Call for Investors
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2026 financial results on Thursday, October 29, 2026, at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://events.q4inc.com/analyst/129835310?pwd=2FG2j7ZZ to pre-register for the call and receive the call information.This call is also being webcast and can be accessed through Baxter's website at www.
Business Wire • Oct 7, 2026

Is Baxter International (BAX) Stock Outpacing Its Medical Peers This Year?
Here is how Baxter International (BAX) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.
Zacks Investment Research • Oct 6, 2026

Are Investors Undervaluing Baxter International (BAX) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks Investment Research • Oct 6, 2026

Baxter Releases Inaugural Connected Hospital Report
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the release of its 2026 Connected Hospital Report, offering new insights into how hospitals across the United States are leveraging technology investments to drive clinical and operational outcomes. Based on a survey of 150 information technology (IT) and nursing leaders, the report examines how hospitals are progressing along a “connected hospital” journey by identifying four distin.
Business Wire • Sep 30, 2026

Here's Why You Should Retain Baxter Stock in Your Portfolio for Now
BAX's portfolio reset and growth in connected care and advanced surgery support prospects, but margins, Novum IQ and China pricing remain risks.
Zacks Investment Research • Sep 24, 2026

Top 3 Health Care Stocks That May Rocket Higher In September
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Benzinga • Sep 21, 2026

Baxter International Inc. (BAX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Baxter International Inc. (BAX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Seeking Alpha • Sep 9, 2026

BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure
Baxter raises its 2026 sales and earnings outlook after strong Q2 growth, though manufacturing costs, tariffs and pricing pressure margins.
Zacks Investment Research • Sep 7, 2026

Baxter Appoints John Rogers Chief Financial Officer
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed John Rogers as executive vice president and chief financial officer (CFO), reporting to Baxter president and chief executive officer (CEO), Andrew Hider, effective Oct. 1, 2026. “John is a proven global finance executive with extensive operational expertise and a successful track record leading complex transformation initiatives,” said Hider. “He is an ideal fit for.
Business Wire • Aug 19, 2026

Baxter Announces Early Tender Results and Upsizing of Previously Announced Cash Tender Offers
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) (“Baxter” or the “Company”) today announced the early results of its previously announced cash tender offers (each, an “Offer” and collectively, the “Offers”) for its validly tendered (and not validly withdrawn) notes set forth below (collectively, the “Notes”). The Offers are being made pursuant to an Offer to Purchase, dated Aug. 4, 2026 (as it may be amended or supplemented from time to time, the “Offer to Purchase”), whi.
Business Wire • Aug 18, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Baxter International Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.